MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-TN-08-0004082
Proventus Life Sciences Private Limited - chemicals in Chennai, Tamil Nadu, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹9.17 Cr
▼ 47% YoY
Net loss · FY 2024
₹3.65 Cr
Net margin -39.8%
EBITDA · FY 2024
-₹37.54 Lakh
EBITDA margin -4.1%
Authorised capital
₹13 Cr
Registered with MCA
Paid-up capital
₹10.95 Cr
Issued & subscribed
Open charges
₹61.89 Cr
Satisfied ₹38.46 Cr
Company age
47 yrs
Est. 1979
Employees · EPFO
68
Provident fund records
About Proventus Life Sciences Private Limited
Data last updated:
Proventus Life Sciences Private Limited is a private limited company based in Chennai, Tamil Nadu, India, a subsidiary of Chemcrown Exports Ltd. It operates in the chemical products segment of the chemicals sector. It was incorporated on 27 June 1979 and has been in existence for over 47 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U24211TN1979PTC159308. Its GSTIN is 33AAACC3092R1ZE (Tamil Nadu).
The company has an authorised share capital of ₹13 Cr and a paid-up capital of ₹10.95 Cr. It was formerly known as Curekrafts Chemicals (I) P Ltd and Curekrafts P Ltd. It is led by directors including Mayank Umesh Bhimsaria and Archana Singhania.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at C – 9 Industrial Area II (Cmda) Maraimalai Nagar, Chennai, Tamil Nadu, India – 603209.
As per the financials filed for FY 2024, the company reported a revenue of ₹9.17 Cr, a decline of 47% compared to the previous year. For the same year it recorded a net loss of ₹3.65 Cr (net margin -39.8%) and EBITDA of -₹37.54 Lakh (EBITDA margin -4.1%). Revenue has declined at a compounded annual rate (CAGR) of 45% over three years and 34% over five years.
The company has about 68 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Proventus Life Sciences. As per MCA filings, the company has open charges of ₹61.89 Cr and satisfied charges of ₹38.46 Cr on record. Court records list 12 cases involving the company, including 2 filed by the company and 10 filed against it; 1 case is pending. The company has 9 deals on record (5 funding rounds, 4 secondary share transfers), with disclosed funding of ₹6.12 Cr; the latest was in January 2014. Its 7 peer companies in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 4 larger and 3 smaller; the largest is Horster Biotek Private Limited with revenue of ₹9.25 Cr.
Proventus Life Sciences Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-TN-08-0004082). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website proventuslife.com.
Company details
CIN U24211TN1979PTC159308
Registration Number 159308
Incorporation Date 27 June 1979
ROC Chennai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Parent Company Chemcrown Exports Ltd
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-TN-08-0004082
Name history
Proventus Life Sciences has undergone 2 name changes throughout its history. The company was previously known as Curekrafts Chemicals (I) P Ltd, and Curekrafts P Ltd. The current legal name is Proventus Life Sciences Private Limited.
| Company Name | Status |
|---|---|
| Proventus Life Sciences Private Limited | Current |
| Curekrafts Chemicals (I) P Ltd | Previous |
| Curekrafts P Ltd | Previous |
CIN history
Proventus Life Sciences has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U24211TN1979PTC159308, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24211TN1979PTC159308 | Current |
| U24211TN1979PTC007870 | Previous |
| U24211WB1979PTC206988 | Previous |
Recognitions & Rankings of Proventus Life Sciences
Contact details
Proventus Life Sciences Private Limited's registered office is in Chennai, Tamil Nadu.
- Social Media
- Registered AddressC – 9 Industrial Area II (Cmda) Maraimalai Nagar, Chennai, Tamil Nadu, India – 603209
- IndustryChemicals, Chemical Products, Medicinal Chemical & Botanical Products, Pharmaceuticals
Comprehensive company report
Proventus Life Sciences Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Proventus Life Sciences operates one associated brand: Proventus Life Sciences. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Services for API manufacturing (lab and commercial scale), scale-up and process development | proventuslife.com |
Business activity
The main business activity of Proventus Life Sciences is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Proventus Life Sciences Private Limited, buy the company report.
Financials of Proventus Life Sciences Private Limited
FY 2024 filings availableProventus Life Sciences Private Limited reported revenue of ₹9.17 Cr (down 47% YoY) for FY 2024.
Revenue · FY 2024
₹9.17 Cr ▼ 47%
Net loss · FY 2024
₹3.65 Cr margin -39.8%
EBITDA · FY 2024
-₹37.54 Lakh margin -4.1%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 47%
3 years · compounded
▼ 45%
5 years · compounded
▼ 34%
EBITDA CAGR growth
1 year
▼ 113%
3 years · compounded
▼ 29%
5 years · compounded
▼ 17%
Revenue has declined at a compounded annual rate (CAGR) of 34% over five years, including a 47% fall in the latest year. EBITDA fell 113% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹37.54 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹3.65 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -4.1% | ||||
| Net Profit Margin | -39.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Proventus Life Sciences Private Limited, buy the company report.
Board of directors of Proventus Life Sciences Private Limited
Proventus Life Sciences has 3 current directors and 21 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mayank Umesh Bhimsaria | Director | 14 Aug 2025 | 1 Years 2 Months | Current |
| Archana Singhania Also directs: Kaizen CNC Centre Private Limited, Lakewater Technologies Limited, Lakewater Retail Private Limited and 1 more | Director | 01 Aug 2022 | 4 Years 3 Months | Current |
| Ayush Sultania Also directs: Lakewater Technologies Limited | Director | 01 Aug 2022 | 4 Years 3 Months | Current |
Peer comparison
Proventus Life Sciences Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Horster Biotek Private Limited | ₹9.25 Cr (FY 2025) | 16.0% | Indore, Madhya Pradesh, India | |||
| Esschem Private Limited | ₹9.23 Cr (FY 2025) | 29.0% | Mumbai, Maharashtra, India | |||
| Omkrown Pharam-Chem Private Limited | ₹9.22 Cr (FY 2025) | 6.0% | Nagar, Shahapur, Belgaum, Karnataka, India | |||
| Shreegen Pharma Limited | ₹9.2 Cr (FY 2023) | -32.0% | Hyderabad, Telangana, India | |||
| Proventus Life Sciences Private Limitedthis company | ₹9.17 Cr (FY 2024) | -₹3.65 Cr | -39.8% | -47.0% | Chennai, Tamil Nadu, India | |
| Thexa Pharma Private Limited | ₹9.03 Cr (FY 2018) | -84.0% | Madgul, Telangana, India | |||
| Xenocor Pharmalab Private Limited | ₹8.98 Cr (FY 2024) | 75.0% | Bangalore, Karnataka, India | |||
| Aptra Synthesis Private Limited | ₹8.84 Cr (FY 2024) | -24.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Proventus Life Sciences Private Limited, buy the company report.
Charges & borrowings
Open charges
₹61.89 Cr
Satisfied charges
₹38.46 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 30 Jul 2025 | 101149981 | Others | ₹27 Cr | Open | |
| 21 Sep 2022 | 100653972 | Others | ₹19 Cr | Open | |
| 17 Mar 2022 | 100558123 | Others | ₹15.5 Cr | Open | |
| 04 Nov 1989 | 90303243 | The Tamilnadu Industrial Investmentcorporation Ltd. | ₹27.27 Lakh | Open | |
| 10 May 1989 | 90299880 | The Tamilnadu Industrial Investmentcorporation Ltd. | ₹2.54 Lakh | Open |
To see the full charge records of Proventus Life Sciences Private Limited, buy the company report.
Total charge records: 10 View all charges
Deals & funding
Proventus Life Sciences Private Limited has 9 deals on record (5 funding rounds, 4 secondary share transfers), with disclosed funding of ₹6.12 Cr; the latest was in January 2014.
Total deals
9
Funding rounds
5
Secondary share transfers
4
Disclosed funding
₹6.12 Cr
Deals on record (5 of 9)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jan 2014 | Funding round | ₹1.84 Cr | Investors: Chemcrown Exports Limited, BD Bhaiya HUF, an individual |
| Mar 2013 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: H.C Family Trust, Mukund Kumar Bhaiya HUF, 2 individuals |
| Mar 2012 | Secondary share transfer | Undisclosed | Buyer: Manoj Kumar Bhaiya HUF, Mukund Kumar Bhaiya HUF, 2 individuals Seller: an individual |
| Apr 2011 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Apr 2010 | Funding round | ₹1.05 Cr | Investors: Chemcrown Exports Limited, BD Bhaiya HUF |
To see the full deal history of Proventus Life Sciences Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Proventus Life Sciences Private Limited has 12 court cases on record: 2 filed by Proventus Life Sciences, 10 filed against it. 1 case is pending and 11 are disposed.
Total cases
12
Filed by the company
2
Filed against the company
10
Pending
1
Disposed
11
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 6 | 6 | 0 |
| High courts | 6 | 4 | 1 |
Cases on record (5 of 12)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Chennai, Tamil Nadu | Civil suit | Filed against the company by Buzzworks Business Services Pvt Ltd | Disposed |
| Bombay High Court | Court case (LPETN) | Filed against the company by M.J. Chemicals | Pending |
| High Court, TAMIL NADU | Interim or miscellaneous application | Filed by the company against The Commissioner and 3 others | Disposed |
| District court, Rangareddy, Telangana | Civil suit | Filed against the company by Archemedis Laborateries Pvt Ltd. | Disposed |
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summons Private cases SS) | Filed against the company by Ms Aniket Enterprises | Disposed |
To see the full case history of Proventus Life Sciences Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Proventus Life Sciences Private Limited was last rated by Crisil on 12 Aug 2020.
| Rating agency | Rated on | Rating |
|---|---|---|
| Crisil | 12 Aug 2020 |
To see the full credit ratings and regulatory alerts of Proventus Life Sciences Private Limited, buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Proventus Life Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Proventus Life Sciences has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AAACC3092R1ZE | Tamil Nadu | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Proventus Life Sciences Private Limited, buy the company report.
Recent activity
Proventus Life Sciences Private Limited has 24 board changes on record since 2007: 3 appointments and 21 cessations. The latest: Mayank Umesh Bhimsaria ceased to be Additional Director on 29 Sep 2025.
Ceased
Mayank Umesh Bhimsaria ceased to be Additional Director.
Appointed
Mayank Umesh Bhimsaria was appointed as Director.
Charges
A charge with Others amounted to Rs. 27.00 Cr with Charge ID 101149981 was registered on 30 Jul 2025.
AGM
Proventus Life Sciences Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Proventus Life Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chennai.
Ceased
Debashish Datta ceased to be Director.
Ceased
Archana Singhania ceased to be Additional Director.
Ceased
Ayush Sultania ceased to be Additional Director.
Charges
A charge with Others amounted to Rs. 19.00 Cr with Charge ID 100653972 was registered on 21 Sep 2022.
Ceased
Chandan Roy ceased to be Director.
Ceased
Ganga Devi Bhaiya ceased to be Director.
Ceased
Manoj Kumar Bhaiya ceased to be Managing Director.
34 earlier events are in the company report.
Frequently asked questions
Proventus Life Sciences is an active private limited company based in Chennai, Tamil Nadu, India. The company works in chemical products, within the chemicals industry. It was incorporated on 27 June 1979 (47+ years old) and is registered under CIN U24211TN1979PTC159308.
Proventus Life Sciences has 3 current directors:
- Mayank Umesh Bhimsaria - Director
- Archana Singhania - Director
- Ayush Sultania - Director
The latest financial statements of Proventus Life Sciences on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Proventus Life Sciences is 33AAACC3092R1ZE, registered in Tamil Nadu.
The CIN (Corporate Identification Number) of Proventus Life Sciences is U24211TN1979PTC159308. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Proventus Life Sciences has 12 court cases on record: 2 filed by the company and 10 filed against it. 1 is pending. Most are in the district courts.
Proventus Life Sciences was incorporated on 27 June 1979, making it 47+ years old. It is registered with the Registrar of Companies, Chennai.
Proventus Life Sciences has 9 deals on record (5 funding rounds, 4 secondary share transfers), with disclosed funding of ₹6.12 Cr; the latest was in January 2014.
The peers of Proventus Life Sciences by revenue are Horster Biotek Private Limited, Esschem Private Limited, Omkrown Pharam-Chem Private Limited, Shreegen Pharma Limited, Thexa Pharma Private Limited and 2 more, all in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Mayank Umesh Bhimsaria ceased to be Additional Director on 29 Sep 2025. Mayank Umesh Bhimsaria was appointed as Director on 14 Aug 2025. Debashish Datta ceased to be Director on 26 Nov 2022. Proventus Life Sciences has 24 board changes on record in total.
Yes, Proventus Life Sciences is registered as a small enterprise under Udyam registration (number: UDYAM-TN-08-0004082).
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages